4//SEC Filing
Hamdy Ahmed MD 4
Accession 0000950170-24-066201
CIK 0001796129other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 8:54 PM ET
Size
5.6 KB
Accession
0000950170-24-066201
Insider Transaction Report
Form 4
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-05-23+53,254→ 200,000 totalExercise: $7.38Exp: 2034-03-06→ Common Stock (53,254 underlying)
Footnotes (2)
- [F1]The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
- [F2]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001458506
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 8:54 PM ET
- Size
- 5.6 KB